The Technical Analyst
Pila Pharma AB (publ) [PILA.ST]
Exchange: STO Sector: Healthcare Industry: Biotechnology
Pila Pharma AB (publ) Price, Forecast, Insider, Ratings, Fundamentals & Signals
0.42% SEK2.41
America/New_York / 17 mai 2024 @ 07:59
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 57.34 mill |
| EPS: | -0.470 |
| P/E: | -5.13 |
| Earnings Date: | Feb 28, 2024 |
| SharesOutstanding: | 23.79 mill |
| Avg Daily Volume: | 0.0358 mill |
| RATING 2024-05-17 |
|---|
| C+ |
| Sell |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Sell | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Strong Sell | |
| DE: | Neutral | |
| P/E: | Sell | |
| Price To Book: | Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | n/a | n/a | ||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt | n/a | n/a | n/a | n/a | n/a |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -5.13 | sector: PE 19.76 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| -0.01x |
| Company: PE -5.13 | industry: PE 491.84 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
SEK-0.497 (-120.62%) SEK-2.91 |
| Date: 2024-05-18 |
| Expected Trading Range (DAY) |
|---|
|
SEK 2.07 - 2.75 ( +/- 13.98%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
Forecast
1: 14:09 - SEK2.41
Forecast 2: 14:59 - SEK2.38
Forecast 3: 15:39 - SEK2.40
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | SEK2.41 (0.42% ) |
| Volume | 0.0738 mill |
| Avg. Vol. | 0.0358 mill |
| % of Avg. Vol | 206.18 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For PILA.ST
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
PILA.ST
PILA PHARMA AB (publ) operates as a clinical stage pharmaceutical company in Sweden. It is developing XEN-D0501, a TRPV1 antagonist that has completed two phase 2a clinical trials for type 2 diabetes. PILA PHARMA AB (publ) was incorporated in 2014 and is based in Malmö, Sweden.